MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MP-23-0007351
Cyano Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹85.89 Cr
▲ 38% YoY
Net profit · FY 2024
₹1.59 Cr
Net margin 1.8%
EBITDA · FY 2024
₹4.64 Cr
EBITDA margin 5.4%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹49.45 Lakh
Issued & subscribed
Open charges
₹40.49 Cr
Satisfied ₹2.39 Cr
Company age
26 yrs
Est. 2000
Employees · EPFO
36
Provident fund records
About Cyano Pharma Private Limited
Data last updated:
Cyano Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 February 2000 and has been in existence for over 26 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2000PTC283629. Its GSTIN is 23AACCC2242F1ZC (Madhya Pradesh). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹49.45 Lakh. It is led by directors Sureshchandra Chourasiya and Mahendra Patidar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6 Gr. Floor Patnawala Compound Opp. Shreyas Lbs Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086.
As per the financials filed for FY 2024, the company reported a revenue of ₹85.89 Cr, a growth of 38% compared to the previous year. For the same year it recorded a net profit of ₹1.59 Cr (net margin 1.8%) and EBITDA of ₹4.64 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 10% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹40.49 Cr and satisfied charges of ₹2.39 Cr on record. Court records list 12 cases involving the company, including 6 filed by the company and 6 filed against it; 2 cases are pending. The company has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.66 Cr; the latest was in September 2022. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Appasamy Ocular Devices Private Limited with revenue of ₹87.93 Cr.
Cyano Pharma Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0007351). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cyanopharmagroup.com.
Company details
CIN U24232MH2000PTC283629
Registration Number 283629
Incorporation Date 29 February 2000
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MP-23-0007351
CIN history
Cyano Pharma has one previous CIN (Corporate Identification Number): U24232MP2000PTC014072. The current CIN is U24232MH2000PTC283629, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232MH2000PTC283629 | Current |
| U24232MP2000PTC014072 | Previous |
Recognitions & Rankings of Cyano Pharma
Contact details
Cyano Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is cyanopharmagroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address6 Gr. Floor Patnawala Compound Opp. Shreyas Lbs Marg Ghatkopar (W), Mumbai, Maharashtra, India – 400086
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cyano Pharma Private Limited, buy the company report.
Comprehensive company report
Cyano Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activities of Cyano Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cyano Pharma Private Limited, buy the company report.
Financials of Cyano Pharma Private Limited
FY 2025 filings availableCyano Pharma Private Limited reported revenue of ₹85.89 Cr (up 38% YoY) for FY 2024.
Revenue · FY 2024
₹85.89 Cr ▲ 38%
Net profit · FY 2024
₹1.59 Cr margin 1.8%
EBITDA · FY 2024
₹4.64 Cr margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 12%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 9%
5 years · compounded
▲ 11%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 38% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.59 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 1.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cyano Pharma Private Limited, buy the company report.
Board of directors of Cyano Pharma Private Limited
Cyano Pharma has 2 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sureshchandra Chourasiya | Director | 01 Sep 2010 | 16 Years 1 Months | Current |
| Mahendra Patidar | Director | 10 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Cyano Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Appasamy Ocular Devices Private Limited | ₹87.93 Cr (FY 2022) | 60.0% | Chennai, Tamil Nadu, India | |||
| BDH Industries Limited | ₹87.41 Cr (FY 2024) | 16.0% | Mumbai, Maharashtra, India | |||
| Vidacare Medica Private Limited | ₹87.17 Cr (FY 2025) | -13.0% | Mumbai, Maharashtra, India | |||
| Health Biotech Limited | ₹86.89 Cr (FY 2025) | -22.0% | Chandigarh, India | |||
| Cyano Pharma Private Limitedthis company | ₹85.89 Cr (FY 2024) | ₹1.59 Cr | 1.8% | 38.0% | 36 | Mumbai, Maharashtra, India |
| Zenara Pharma Private Limited | ₹85.73 Cr (FY 2025) | 3.0% | Hyderabad, Telangana, India | |||
| D.D. Pharmaceuticals Pvt. Ltd | ₹85.6 Cr (FY 2024) | 20.0% | Sitapura, Tonk Road, Jaipur., Rajasthan, India | |||
| Sidmak Laboratories (India) Private Limited | ₹85.07 Cr (FY 2025) | -6.0% | Valsad, Gujarat, India | |||
| Nava Healthcare Private Limited | ₹84.21 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India |
To see the full peer comparison of Cyano Pharma Private Limited, buy the company report.
Auditor
Cyano Pharma Private Limited is audited by Sethiya Khandelwal & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sethiya Khandelwal & Co. | FY 2023 | 004058C |
Shareholding
The shareholding of Cyano Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cyano Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹40.49 Cr
Satisfied charges
₹2.39 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Feb 2023 | 100676619 | Sidbi | ₹2.18 Cr | Open | |
| 19 Oct 2020 | 100396038 | State Bank of India | ₹17 Lakh | Open | |
| 05 Mar 2004 | 90204135 | State Bank of India | ₹38.14 Cr | Open | |
| 08 Oct 2024 | 101019838 | Others | ₹9.95 Lakh | Satisfied | |
| 01 Jun 2020 | 100342213 | State Bank of India | ₹94 Lakh | Satisfied |
To see the full charge records of Cyano Pharma Private Limited, buy the company report.
Total charge records: 9 View all charges
Deals & funding
Cyano Pharma Private Limited has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.66 Cr; the latest was in September 2022.
Total deals
11
Secondary share transfers
7
Funding rounds
4
Disclosed funding
₹6.66 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Funding round | ₹23.8 Lakh | Investors: Gems Equities and Securities Private Limited |
| Mar 2014 | Funding round | ₹1.45 Cr | Investors: Starline Equifin Private Limited |
| May 2010 | Secondary share transfer | Undisclosed | Buyer: Formo Plast Pvt.Ltd. , Cyano Finance and Sales Private Limited , Libra Healthcare Private Limited Seller: Yash-V-Jewels Limited , MGRIP Marketing Private Limited, Shri Balaji Sainath Buildwell Private Limited, an individual |
| Mar 2010 | Funding round | ₹3.03 Cr | Investors: Acumen Paper Binders Private Limited , Bhagirath Industries Limited, MGRIP Marketing Private Limited |
| Mar 2008 | Funding round | ₹1.94 Cr | Investors: Surbhi Networking & Broadcasting Private Limited , Uniword Bartercard Private Limited , Startrans Logistics Private Limited , an individual |
To see the full deal history of Cyano Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Cyano Pharma Private Limited has 12 court cases on record: 6 filed by Cyano Pharma, 6 filed against it. 2 cases are pending and 10 are disposed.
Total cases
12
Filed by the company
6
Filed against the company
6
Pending
2
Disposed
10
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 6 | 3 | 2 |
| High courts | 6 | 3 | 0 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Appeal | Filed against the company by Nestor Pharmaceuticals Limited | Disposed |
| High Court | Writ petition | Filed by the company against Chhattisgarh Medical Services Corporation Ltd., and 1 other | Disposed |
| District court, SHIVAMOGGA, Karnataka | Criminal miscellaneous application | Filed by the company against Karnataka State at the Instance of Assistant Drugs Controller-2, Shivamogga | Pending |
| District court, Darbhanga, Bihar | Court case (G.o) | Filed against the company by State of Bihar | Pending |
| District court, Sawai Madhopur, Rajasthan | Court case (Cr. Misc. Cases) | Filed against the company by an individual | Disposed |
To see the full case history of Cyano Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cyano Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Cyano Pharma Private Limited has a workforce of 36 employees on its EPFO records as of Mar 29, 2025, across 1 active EPFO establishment.
Employee count
36
Active EPFO establishments
1
Employee growth
12.5%
GST
Cyano Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
Total GSTINs
3
Active
2
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCC2242F1ZC | Madhya Pradesh | Active | 01 Jul 2017 |
| 09AACCC2242F1Z2 | Uttar Pradesh | Active | 02 Jan 2019 |
To see the full GST registrations and return filing status of Cyano Pharma Private Limited, buy the company report.
Recent activity
Cyano Pharma Private Limited has 12 board changes on record since 2010: 2 appointments and 10 cessations. The latest: Ramesh Shah ceased to be Additional Director on 11 Mar 2025.
AGM
Cyano Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India of Rs. 3,814.00 Lakh registered on 05 Mar 2004 with Charge ID 90204135 was modified on 22 Sep 2025.
Charges
A charge registered on 08 Oct 2024 via Charge ID 101019838 with Others was fully satisfied on 08 Jul 2025.
Filing
Cyano Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Ramesh Shah ceased to be Additional Director.
Charges
A charge with Others amounted to Rs. 9.95 Lakh with Charge ID 101019838 was registered on 08 Oct 2024.
Ceased
Mahendra Patidar ceased to be Additional Director.
Appointed
Mahendra Patidar was appointed as Director.
Charges
A charge registered on 01 Jun 2020 via Charge ID 100342213 with State Bank Of India was fully satisfied on 06 Mar 2023.
Charges
A charge registered on 28 Apr 2020 via Charge ID 100337087 with State Bank Of India was fully satisfied on 06 Mar 2023.
Charges
A charge with Sidbi amounted to Rs. 218.00 Lakh with Charge ID 100676619 was registered on 09 Feb 2023.
Ceased
Smitesh Shah ceased to be Additional Director.
19 earlier events are in the company report.
Frequently asked questions
Cyano Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 February 2000 (26+ years old) and is registered under CIN U24232MH2000PTC283629.
Cyano Pharma has 2 current directors:
- Sureshchandra Chourasiya - Director
- Mahendra Patidar - Director
The latest financial statements of Cyano Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cyano Pharma is 23AACCC2242F1ZC, registered in Madhya Pradesh. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 09AACCC2242F1Z2 (Uttar Pradesh).
The CIN (Corporate Identification Number) of Cyano Pharma is U24232MH2000PTC283629. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cyano Pharma has 12 court cases on record: 6 filed by the company and 6 filed against it. 2 are pending. Most are in the district courts.
Cyano Pharma was incorporated on 29 February 2000, making it 26+ years old. It is registered with the Registrar of Companies, Mumbai.
Cyano Pharma has 11 deals on record (7 secondary share transfers, 4 funding rounds), with disclosed funding of ₹6.66 Cr; the latest was in September 2022.
The peers of Cyano Pharma by revenue are Appasamy Ocular Devices Private Limited, BDH Industries Limited, Vidacare Medica Private Limited, Health Biotech Limited, Zenara Pharma Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ramesh Shah ceased to be Additional Director on 11 Mar 2025. Mahendra Patidar ceased to be Additional Director on 29 Sep 2023. Mahendra Patidar was appointed as Director on 10 Mar 2023. Cyano Pharma has 12 board changes on record in total.
Yes, Cyano Pharma is registered as a medium enterprise under Udyam registration (number: UDYAM-MP-23-0007351).